L-glutamine is vital to supporting optimal Phase II detoxification and helps stabilize blood glucose levels
GLP-1 (glucagon-like peptide-1) is an incretin hormone naturally produced in the intestines that influences multiple aspects of digestive function
By promoting insulin release and inhibiting glucagon secretion, GLP-1 agonists effectively lower blood sugar levels, providing a valuable therapeutic option for individuals with type 2 diabetes
To break a plateau, consider changing up your routine: maybe increase your exercise intensity or frequency, reassess portion sizes to ensure you havent started eating a bit more, or add a new element like a high-protein snack to preserve muscle
As an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide is currently undergoing Phase 3 clinical trials for obesity and type 2 diabetes
Available from: The glucagon like peptide-1 receptor is a G proteincoupled receptor